These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 31745697)
21. Comparison of fatigue, depression, and anxiety as factors affecting posttreatment health-related quality of life in lung cancer survivors. Jung JY; Lee JM; Kim MS; Shim YM; Zo JI; Yun YH Psychooncology; 2018 Feb; 27(2):465-470. PubMed ID: 28755492 [TBL] [Abstract][Full Text] [Related]
22. Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls. Boekhout AH; Rogiers A; Jozwiak K; Boers-Sonderen MJ; van den Eertwegh AJ; Hospers GA; de Groot JWB; Aarts MJB; Kapiteijn E; Ten Tije AJ; Piersma D; Vreugdenhil G; van der Veldt AA; Suijkerbuijk KPM; Rozeman EA; Neyns B; Janssen KJ; van de Poll-Franse LV; Blank CU Acta Oncol; 2021 Jan; 60(1):69-77. PubMed ID: 32924708 [TBL] [Abstract][Full Text] [Related]
23. Symptoms of anxiety and depression among colorectal cancer survivors from the population-based, longitudinal PROFILES Registry: Prevalence, predictors, and impact on quality of life. Mols F; Schoormans D; de Hingh I; Oerlemans S; Husson O Cancer; 2018 Jun; 124(12):2621-2628. PubMed ID: 29624635 [TBL] [Abstract][Full Text] [Related]
24. Health-related quality of life in long-term disease-free breast cancer survivors versus female population controls in Germany. Doege D; Thong MS; Koch-Gallenkamp L; Bertram H; Eberle A; Holleczek B; Pritzkuleit R; Waldeyer-Sauerland M; Waldmann A; Zeissig SR; Jansen L; Brenner H; Arndt V Breast Cancer Res Treat; 2019 Jun; 175(2):499-510. PubMed ID: 30826935 [TBL] [Abstract][Full Text] [Related]
25. Home-based multidimensional survivorship programmes for breast cancer survivors. Cheng KKF; Lim YTE; Koh ZM; Tam WWS Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011152. PubMed ID: 28836379 [TBL] [Abstract][Full Text] [Related]
26. Health-Related Quality of Life in KEYNOTE-010: a Phase II/III Study of Pembrolizumab Versus Docetaxel in Patients With Previously Treated Advanced, Programmed Death Ligand 1-Expressing NSCLC. Barlesi F; Garon EB; Kim DW; Felip E; Han JY; Kim JH; Ahn MJ; Fidler MJ; Gubens MA; de Castro G; Surmont V; Li Q; Deitz AC; Lubiniecki GM; Herbst RS J Thorac Oncol; 2019 May; 14(5):793-801. PubMed ID: 30711649 [TBL] [Abstract][Full Text] [Related]
27. Adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma: Health-related quality of life from the randomized phase 3 KEYNOTE-716 study. Khattak MA; Luke JJ; Long GV; Ascierto PA; Rutkowski P; Schadendorf D; Robert C; Grob JJ; de la Cruz Merino L; Del Vecchio M; Spagnolo F; Mackiewicz J; Chiarion-Sileni V; Carlino MS; Mohr P; De Galitiis F; Ross MI; Eroglu Z; Chen K; Jiang R; Fukunaga-Kalabis M; Krepler C; Eggermont AMM; Kirkwood JM Eur J Cancer; 2022 Nov; 176():207-217. PubMed ID: 36202690 [TBL] [Abstract][Full Text] [Related]
28. Growth hormone deficiency and neurocognitive function in adult survivors of childhood acute lymphoblastic leukemia. Krull KR; Li C; Phillips NS; Cheung YT; Brinkman TM; Wilson CL; Armstrong GT; Khan RB; Merchant TE; Sabin ND; Srivastava D; Pui CH; Robison LL; Hudson MM; Sklar CA; Chemaitilly W Cancer; 2019 May; 125(10):1748-1755. PubMed ID: 30690723 [TBL] [Abstract][Full Text] [Related]
29. Older ovarian cancer survivors report lower long-term health-related quality of life than younger survivors: A study from the population-based profiles registry. van Walree IC; Hamaker ME; van de Poll-Franse LV; Vos MC; Boll D; van Huis-Tanja LH; Ezendam NPM Gynecol Oncol; 2019 May; 153(2):391-398. PubMed ID: 30772033 [TBL] [Abstract][Full Text] [Related]
30. Exploring prostate cancer survivors' self-management behaviours and examining the mechanism effect that links coping and social support to health-related quality of life, anxiety and depression: a prospective longitudinal study. Paterson C; Robertson A; Nabi G Eur J Oncol Nurs; 2015 Apr; 19(2):120-8. PubMed ID: 25497067 [TBL] [Abstract][Full Text] [Related]
31. Pilot study of a multimodal intervention to enhance sexual function in survivors of hematopoietic stem cell transplantation. El-Jawahri A; Fishman SR; Vanderklish J; Dizon DS; Pensak N; Traeger L; Greer JA; Park ER; Markovitz N; Waldman L; Hunnewell C; Saylor M; Driscoll J; Li Z; Spitzer TR; McAfee S; Chen YB; Temel JS Cancer; 2018 Jun; 124(11):2438-2446. PubMed ID: 29537491 [TBL] [Abstract][Full Text] [Related]
32. Impact of the COVID-19 Pandemic on Patient-Reported Outcomes of Breast Cancer Patients and Survivors. Bargon CA; Batenburg MCT; van Stam LE; Mink van der Molen DR; van Dam IE; van der Leij F; Baas IO; Ernst MF; Maarse W; Vermulst N; Schoenmaeckers EJP; van Dalen T; Bijlsma RM; Young-Afat DA; Doeksen A; Verkooijen HM JNCI Cancer Spectr; 2021 Feb; 5(1):pkaa104. PubMed ID: 33437925 [TBL] [Abstract][Full Text] [Related]
33. Physical activity and health-related quality of life in multiple myeloma survivors: the PROFILES registry. Servadio M; Cottone F; Sommer K; Oerlemans S; van de Poll-Franse L; Efficace F BMJ Support Palliat Care; 2020 Dec; 10(4):e35. PubMed ID: 31253733 [TBL] [Abstract][Full Text] [Related]
34. Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire. van Leeuwen M; Husson O; Alberti P; Arraras JI; Chinot OL; Costantini A; Darlington AS; Dirven L; Eichler M; Hammerlid EB; Holzner B; Johnson CD; Kontogianni M; Kjær TK; Morag O; Nolte S; Nordin A; Pace A; Pinto M; Polz K; Ramage J; Reijneveld JC; Serpentini S; Tomaszewski KA; Vassiliou V; Verdonck-de Leeuw IM; Vistad I; Young TE; Aaronson NK; van de Poll-Franse LV; Health Qual Life Outcomes; 2018 Jun; 16(1):114. PubMed ID: 29866185 [TBL] [Abstract][Full Text] [Related]
35. Neurocognitive, psychosocial, and quality-of-life outcomes in adult survivors of childhood non-Hodgkin lymphoma. Ehrhardt MJ; Mulrooney DA; Li C; Baassiri MJ; Bjornard K; Sandlund JT; Brinkman TM; Huang IC; Srivastava DK; Ness KK; Robison LL; Hudson MM; Krull KR Cancer; 2018 Jan; 124(2):417-425. PubMed ID: 28915338 [TBL] [Abstract][Full Text] [Related]
36. Risk factors for neurocognitive impairment, emotional distress, and poor quality of life in survivors of pediatric rhabdomyosarcoma: A report from the Childhood Cancer Survivor Study. van der Plas E; Darji H; Srivastava DK; Schapiro M; Jeffe D; Perkins S; Howell R; Leisenring W; Armstrong GT; Oeffinger K; Krull K; Edelstein K; Hayashi RJ Cancer; 2024 Jun; 130(12):2224-2236. PubMed ID: 38373075 [TBL] [Abstract][Full Text] [Related]
37. Pembrolizumab Utilization and Outcomes for Advanced Melanoma in US Community Oncology Practices. Cowey CL; Liu FX; Black-Shinn J; Stevinson K; Boyd M; Frytak JR; Ebbinghaus SW J Immunother; 2018; 41(2):86-95. PubMed ID: 29252916 [TBL] [Abstract][Full Text] [Related]
38. Changes in health-related quality of life among gynecologic cancer survivors during the two years after initial treatment: a longitudinal analysis. Zandbergen N; de Rooij BH; Vos MC; Pijnenborg JMA; Boll D; Kruitwagen RFPM; van de Poll-Franse LV; Ezendam NPM Acta Oncol; 2019 May; 58(5):790-800. PubMed ID: 30698069 [No Abstract] [Full Text] [Related]
39. Neurocognitive, Quality of Life, and Behavioral Outcomes for Patients With Covert Stroke After Cardiac Surgery: Exploratory Analysis of Data From a Prospectively Randomized Trial. Lewis C; Levine A; Balmert LC; Chen L; Sherwani SS; Nemeth AJ; Grafman J; Gottesman R; Brown CH; Hogue CW Anesth Analg; 2021 Nov; 133(5):1187-1196. PubMed ID: 34319914 [TBL] [Abstract][Full Text] [Related]
40. Psychological reactions and quality of life in patients with posterior uveal melanoma treated with ruthenium plaque therapy or enucleation: a one year follow-up study. Brandberg Y; Kock E; Oskar K; af Trampe E; Seregard S Eye (Lond); 2000 Dec; 14(Pt 6):839-46. PubMed ID: 11584839 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]